Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Penumbra (PEN) Research & Development (2016 - 2025)

Penumbra (PEN) has disclosed Research & Development for 12 consecutive years, with $21.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 8.92% to $21.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $89.8 million, a 5.29% decrease, with the full-year FY2025 number at $89.8 million, down 5.29% from a year prior.
  • Research & Development was $21.8 million for Q4 2025 at Penumbra, down from $22.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $25.2 million in Q3 2024 to a low of $18.0 million in Q4 2022.
  • A 5-year average of $21.6 million and a median of $21.5 million in 2023 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: skyrocketed 39.63% in 2021, then fell 10.35% in 2025.
  • Penumbra's Research & Development stood at $18.1 million in 2021, then dropped by 0.62% to $18.0 million in 2022, then grew by 22.14% to $21.9 million in 2023, then dropped by 8.81% to $20.0 million in 2024, then rose by 8.92% to $21.8 million in 2025.
  • Per Business Quant, the three most recent readings for PEN's Research & Development are $21.8 million (Q4 2025), $22.7 million (Q3 2025), and $23.2 million (Q2 2025).